Funding for this research was provided by:
APTAR, France SAS.
Received: 9 April 2019
Accepted: 2 July 2019
First Online: 21 August 2019
Ethics approval and consent to participate
: Institutional Review Board approval was not required because written informed consent was provided by the subject who provided the data used in the study.
: Consent was provided by the subject who provided CT scans.
: The authors of this manuscript declare relationships with the following companies:Thomas Sartoretti, Manoj Mannil, and Hatem Alkadhi have nothing to disclose.Stefan Biendl declares providing consultancy services to b.e. imaging AG (B.E.IMAGING AG | STREHLGASSE 9 | CH-6430 SCHWYZ), besides performing research at KlusLab—a laboratory dedicated to compounding issues and nasal drug delivery.Matthias Zadory declares providing consultancy services to APTAR France SAS, besides performing research at KlusLab—a laboratory dedicated to compounding issues and nasal drug delivery.John M. Fröhlich declares providing consultancy services to Guerbet, Mallinckrodt, Curium Pharma, b.e.imaging, Philips Healthcare, Siemens Healthineers, Aptar besides being the owner of KlusLab/Akroswiss AG—a laboratory dedicated to compounding issues and nasal drug delivery.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.